Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, has appointed Francis Cano to its board of directors effective November 3, 2009.http://www.infogrok.com/index.php/pharamaceutical/dynavax-ap...
DVAX to present clinical data this weekend at 57th American Society of Hematology in Orlando
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |